[Interferon and tactivin in the treatment program for non-Hodgkin's lymphomas in children during remission].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D002648:Child; D018572:Disease-Free Survival; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D010455:Peptides / Q000627:therapeutic use*; D012074:Remission Induction; D013949:Thymus Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D016898:Interferon-alpha; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin
Interferon i taktivin v programme lecheniia nekhodzhkinskikh limfom u deteĭ v periode remissii.